Immix Biopharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Immix Biopharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Immix Biopharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $7.63M, a 126% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $7.63M +$4.25M +126% Dec 31, 2023 10-K 2024-03-29
Q4 2022 $3.38M +$2.44M +259% Dec 31, 2022 10-K 2024-03-29
Q4 2021 $941K +$439K +87.6% Dec 31, 2021 10-K 2023-03-27
Q4 2020 $501K Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.